FarmaMondo announces the establishment of its Brazilian subsidiary in Sao Paolo, Brazil. The subsidiary will facilitate the company’s vision and strategies in the Brazilian market and will leverage the company global capabilities to make certain, yet to be approved, therapies available to local patients through legal and complaint routes. Brazil is known to be one of the most complex markets for supplying pharmaceuticals yet to be approved. FarmaMondo local entity will facilitate business and will further promote the company global presence initiative.